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Abstract. Raman spectroscopy mapping was used to study ex vivo fresh lung tissues and compare to histology
sections. The Raman mapping measurements revealed differences in the molecular composition of normal lung
tissue, adenocarcinoma, and squamous cell carcinoma (SCC). Molecular heterogeneity of the tissue samples
was well captured by the k -means clustering analysis of the Raman datasets, as confirmed by the correlation
with the adjacent haematoxylin and eosin (H&E) stained tissue sections. The results indicate that the fluores-
cence background varies considerably even in samples that appear structurally uniform in the H&E images, both
for normal and tumor tissue. The results show that characteristic Raman bands can be used to discriminate
between tumorous and nontumorous lung tissues and between adenocarcinoma and SCC tissues. These
results indicate the potential to develop Raman classifications models for lung tissues based on the Raman
spectral differences at the microscopic level, which can be used for tissue diagnosis or treatment stratification.
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1 Introduction
Lung cancer represents a major health concern with a ∼13% to
17% five-year survival rate.1 In 2018, lung cancer was, for both
sexes combined, the leading cause of cancer deaths worldwide.2
Where lung cancer is suspected, initial clinical screening tests
are performed, including chest x-ray and computed tomography,
which is used to both confirm the suspicion and plan further
investigations to guide treatment. Diagnosis and tumor staging
are performed using a variety of clinical techniques, most com-
monly a form of biopsy or needle biopsy, using the least invasive
and safest approach. Occasionally diagnosis is made during
curative surgery, usually where the probability of cancer is very
high.3 The gold standard in diagnosis is the examination of a
biopsy of sufficient quality to allow tumor subtyping and
molecular analysis. One of the main limitations of histopathol-
ogy is that it requires a good quality cytology or biopsy sample,
followed by lengthy tissue preparation (fixation, sectioning, and
staining).
Compared to morphology-based imaging, spectroscopic
techniques may provide more a objective diagnosis based on
molecular analysis of the tissue. A number of spectroscopy tech-
niques have been investigated for ex vivo diagnosis of lung
cancer, including nuclear magnetic resonance,4 (auto)fluores-
cence spectroscopy,5–7 infrared spectroscopy,8,9 and Raman
spectroscopy.10,11 Each technique mentioned has its own advan-
tages and disadvantages in terms of spatial resolution, molecular
specificity, signal strength, data acquisition speed, and cost.
Raman spectroscopy has the advantage of high molecular
specificity12 and has been demonstrated to achieve high diagnosis
accuracy for a range of tissue types which include breast,13,14
skin,15,16 oral tissues,17,18 larynx,19 and prostate.20,21 Furthermore,
Raman spectroscopy is well-suited for in vivo or ex vivo analysis
of fresh tissue as it relies on a back-light scattering configuration,
and tissue remains unmodified after analysis, allowing histopa-
thological examination. Huang et al.10 described the first study
using near-infrared (NIR) Raman spectroscopy to examine lung
cancer tissue. The study demonstrated the presence of many spe-
cific differences in the Raman bands collected from healthy and
malignant lung tissues with a specificity and sensitivity of 92%
and 94%, respectively. More recently, endoscopic Raman probes
utilizing also the high-wavenumber region have been reported,
enabling label-free real-time detection of early lung cancers.22,23
To reduce the laser-induced fluorescence background, 1064-
nm excitation wavelength has also been reported.11,24 Using the
same laser wavelength, Min et al.11 reported spectral differences
in the amide I band at 1659 cm−1 between normal and cancer-
ous fresh lung tissues. Kaminaka et al.25 reported that Raman
bands assigned to collagen at 1666 and 1448 cm−1 could be
used to discriminate between normal and malignant human lung
tissues (tissue fixed in formaldehyde). Although the 1064-nm
laser significantly lowered the fluorescence background, it
increased the acquisition times for the Raman spectra to 5 min.
For in vivo diagnosis, investigations based on Raman fibre
probes have also been reported. These studies developed flex-
ible and thin fiber optic probes that included both laser delivery
and collection of Raman light.26,27 In addition, Raman spectros-
copy has been used to investigate stromal adaptations in preme-
tastatic lungs primed by breast cancer in mouse models.28
Although these studies demonstrated the feasibility of
Raman spectroscopy for diagnosis of lung cancers, the tech-
niques used to record Raman spectra relied on acquiring single
or a low number of Raman spectra from selected regions of the
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tissue. Because of uncertainties related to the small sampling
volume of these Raman probes, single-point measurements can
lead to sampling errors caused by structural and molecular
heterogeneity of the lung tissue. Probes using high-numerical
aperture optics for maximize the collection efficiency of the
Raman photons provide high molecular contrast of tissue struc-
tures but require accurate co-registration with histopathology.
On the other hand, probes with larger sampling volumes (mili-
meter scale) elevate these issues, but limit the spectral contrast
between tissue structures. Raman mapping of lung tissue has
been reported, whereby hyperspectral images of tissue speci-
mens, acquired at resolutions as high as 10 μm, were compared
to histology images to understand the spectral variability at a
microscopic level.29,30 These studies were performed on fro-
zen-sectioned healthy lung tissues and congenital pulmonary
airway malformation but did not include lung cancer tissues.
Here we performed Raman spectral mapping measurements
of fresh nontumorous and cancer lung tissue and compare the
Raman images to histopathology images. The aim of the study
is to provide a better understanding of the effect of tissue hetero-
geneity on the Raman signals and investigate whether the spec-
tral difference between healthy and cancerous tissue can be used
for diagnosis.
2 Materials and Methods
2.1 Collection of Tissue Samples
Lung tissue samples were collected and analyzed at Nottingham
University Hospitals NHS Trust. The samples were collected
by the Nottingham Health Science Biobank (NHSB) after
obtaining patient consent (ethical approval NHSB REC refer-
ence 15/NW/0685). All tissue specimens were received fresh
in the Histopathology Department within 20 min of surgery.
Surgery included left, right, lower, higher, or partial lobectomy
and thoracoscopy. A total of 18 lung tissue samples were
investigated.
2.2 Tissue Preparation and Histopathology
Assessment
Within 20 min following excision, samples of fresh lung tissues
were cut in two adjacent blocks: a “Raman block” (used for
Raman analysis) and a “reference block” (used for reference
analysis by paraffin embedded histology). The Raman blocks
were stored frozen (−20°C) to minimize alteration. Prussian
blue ink was used to paint the outer edge of the reference block
to maintain tissue orientation relative to the Raman block when
performing the sectioning histology. The reference block was
then placed in formalin for fixation, then cut into consecutive
sections using a microtome, followed by haematoxylin and
eosin (H&E) staining. The H&E sections were assessed by
an experienced histopathology consultant (I Soomro). The blue
ink was a visual marker to confirm that the section is an adjacent
section to the surface of the Raman block, enabling us to cor-
relate the Raman spectral maps to specific structures observed in
the H&E section. For Raman spectroscopy experiments, the
Raman blocks were defrosted and thoroughly rinsed in phos-
phate-buffered saline (PBS) at room temperature in order to
remove superficial blood (avoids thermal damage caused by
absorption of laser light). The tissue was oriented with the cut
surface facing the laser beam on the quartz slide. To avoid tissue
drying during the Raman measurements, the tissue was main-
tained moist using PBS.
2.3 Raman Spectroscopy
The Raman spectroscopy measurements were carried out using
a Raman microspectrometer based on an inverted optical micro-
scope (Nikon Eclipse Ti-U), 785-nm laser (Xtra, Toptica), and
microscope stage (Proscan III, Prior). The microscope was con-
nected with an optical fibre (diameter 100 μm) to a spectrometer
with a 600-lines∕mm grating (Oriel 77 200, Newport) and deep
depletion back-illuminated CCD (Andor iDus DU-401-A-RR-
DD). The 785-nm laser was focused on the sample through a
60× 1.2 NA oil-immersion objective (RiverD International),
providing 160-mW laser power at the sample. We estimate that
the sampling volume was ∼5 μm laterally and ∼50 μm axially.
Raman maps were recorded in mapping mode with 20 μm step
size, with an acquisition time of 1 s per spectrum. The instru-
ment was calibrated using the Raman bands of 1,4 bis (2-meth-
ylstyryl) benzene and 5.4-acetamidophenol. For three lung
samples (one with tumor cells and two normal, with emphy-
sema), the histology assessment carried out after the Raman
measurements indicated thermal damage caused by laser expo-
sure. All Raman spectra were dominated by a high-background
signal caused likely by the formation of carbon material.
Therefore, these tissues are not presented in this study. Although
all tissue samples were thoroughly rinsed in PBS prior to the
Raman measurements, it is likely that the damage was induced
by traces of blood or other contaminants with strong absorption
at 785 nm.
2.4 Data Analysis
After removal of cosmic ray peaks Raman spectra, k-means
clustering was applied on the dataset, adjusting the number
of clusters until the structures in the k-means map resembled
the structures observed in the H&E images. To highlight the
differences in the Raman spectra, further preprocessing was
applied: a baseline subtraction (fifth-order polynomial fitting31)
and zero mean and unity vector normalization was applied to all
Raman spectra.4,32 This was then followed by principal compo-
nent analysis (PCA).
Given that the tissue shape and size changes during the his-
tology processing (size changes ranged from 15% to 30%), large
errors in co-registration of the Raman images and histology
were found. Therefore, instead, the following procedure was
used. First, the location of the area analyzed by Raman spectros-
copy was recorded relative to the whole area of the tissue. By
comparing the overall shape of the tissue with the H&E slide, the
location of the scanned area on the H&E image was roughly
identified. Then, k-means analysis was carried out on the
Raman dataset by increasing step wise the number of clusters
until the morphological features in the k-means maps could
be identified and correlated with tissue structures observed in
the H&E section.
3 Results and Discussion
Figure 1 presents a schematic of the measurement protocols and
highlights the numbers and types of tissue samples included in
the study. The analysis of the Raman spectra of lung tissue
revealed that for four out of the 15 tissue samples investigated,
the Raman bands were completely covered by a strong laser-
induced fluorescence background, at all locations in the Raman
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maps. Tissue samples with this behavior included both nonma-
lignant and malignant lung tissues. Two examples, one normal
and one adenocarcinoma, are presented in Fig. 2. In the case of
the adenocarcinoma sample presented in Fig. 2(a), the area of
the tissue analyzed consisted of a nest of tumor cells with hyper-
chromasia. The maximum intensity of the fluorescence emission
in the measured spectra ranged from 20,000 counts to higher
than 65,000 counts, which is the maximum pixel well of the
spectrometer CCD. For the nonmalignant tissue in Fig. 2(b), the
H&E indicated that the analyzed region was made of interstitial
fibrosis and emphysema. We recorded the maximum fluores-
cence intensity varying from 4000 counts to 14,000 counts.
For this group of samples, the spectral mapping measure-
ments indicated a high variance in the intensity of fluorescence
emission, even for regions of the sample considered structurally
homogenous after histopathology evaluation. No particular
structure in the tissue could be reliably identified as the source
of the laser-induced fluorescence emission.
For the remaining 11 samples, well-defined Raman bands
were detected in the measured spectra, despite the presence
of a relatively strong fluorescence background, in agreement
with previous reports.10,27 This set of samples included nonma-
lignant lung tissue, squamous cell carcinoma (SCC), and
adenocarcinoma.
In total, 17,700 Raman spectra were collected from nonma-
lignant lung tissue samples from three distinct patients. Figure 3
presents typical examples of Raman spectral maps and centroid
Raman spectra after k-means analysis of the spectral maps.
The spectra in Fig. 3 contain Raman bands that can be assigned
to all major groups of biomolecules found in lung tissue.10,25,27,29
Raman bands corresponding to molecular vibrations in proteins
include the protein backboneC–Cvibrations (935 cm−1), amide I
(1655 cm−1), amide III (1266 to 1360 cm−1). Molecular vibra-
tions of phospholipids lead to intense Raman bands at 1078,
1302, and 1445 cm−1 and some amino acids have characteristic
Raman bands, such as phenylalanine (1003 cm−1), proline
and valine (935 cm−1), and tryptophan (1266, 1618 cm−1).
Additionally, Raman spectra of nucleic acids are typically
dominated by bands at 788, 1098, 1322, and 1335 cm−1.
Contributions from blood can be identified by the Raman bands
at 1370, 1577, and 1620 cm−1, which were also identified by
Krafft et al.29 andassigned tohaemoglobin.Compared toprevious
studies, we found some differences. For example, we do not
observe the Raman band at 1123 cm−1 from proteins mentioned
by Huang et al.10 but we detected a band at 1128 cm−1 instead.
Also, in the case of sample (a), additional bands were observed at
1546
and 1605 cm−1 attributed to tryptophan and phenylalanine,
respectively.10
The pseudocolor images obtained by k-means clustering
analysis of the Raman measurements confirm the molecular
heterogeneity of the samples. For sample (a), which present fib-
rosis, macrophage, inflamed cells, and fibrosis, the inspection of
the centroid Raman spectra indicated significant differences
related to both Raman bands and fluorescence emission.
Variations in protein content were indicated by differences in
band intensities at 855, 935, 1303, and 1252 cm−1 and collagen
bands at 935 and 1252 cm−1.12 Sample B, characterized by a
denser collagen network compared to sample (a), presents
emphysema, chronic inflammation, and interstitial fibrosis.
The three major clusters generated by the k-means accounted
for 85% of the area of the Raman map. Although the intensity
of the fluorescence emission varied by 50% within the clusters,
the main differences in the Raman spectra were observed mainly
at 1078, 1128, and 1208 cm−1, which can be associated to phos-
pholipids, proteins, and specific amino acids, such as tryptophan
and phenylalanine.10,12
Next, we analyzed five tissue samples from four patients with
SCC (total 16,300 Raman spectra). Two typical examples of
Raman maps analyzed by k-means clustering are presented in
Fig. 4. Overall, the spectra of SCC show Raman bands that were
also present in the spectra of normal lung tissue, such as bands at
823, 876, 935, 1004, 1123, 1152, 1265, 1302, 1335, 1445, 1552,
1618, and 1655 cm−1.10
The pseudocolor images obtained by k-means clustering
show that the Raman spectral maps capture the microscopic
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Fig. 1 Schematic description of the tissue preparation steps and study protocol.
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molecular and structural heterogeneity of the lung tissue sam-
ples well. The H&E images of the two samples indicated that
the tissue samples had a variable number of cells within the
stroma, which were well discriminated in the Raman spectral
maps. Both samples showed poorly differentiated squamous
cells. The centroid spectrum corresponding to cluster 2 for sam-
ple (a) corresponds to a region of connective tissue, which is
distinguishable by stroma fibres and tumor cells. Tissue sample
(a) also presents lymphoid follicles in tumor stroma with germi-
nal centers. This region is richer in collagen content compared to
the other regions from the same tissue and exhibits a higher level
of fluorescence intensity. In contrast, cluster 1 correlates with a
region of highly concentrated cells, grouped together. This
region is characterized by a spectrum with significantly lower
fluorescent intensity (twofold lower). The tissue region in
Fig. 4(b) was selected as an area containing a large number
of tumor cells and little stroma. The two clusters presented cor-
respond to a high content of tumor cells. The clusters in yellow
and green, representing the thin stroma, presented a level of
fluorescence background reaching 2760 counts for the peak
at 750 cm−1. The increased fluorescent background is correlated
with the lower content of tumor cells. The higher number of
cells in this region of sample (b) also led to a higher intensity
of the Raman bands assigned to nucleic acids at 788 cm−1
(phosphodiester bond O─P─O stretching vibration) and
1098 cm−1 (phosphodioxy PO2− group).
12 A higher intensity
between the Raman band around 1090 cm−1 was also observed
by Huang et al.10 and assigned to phospholipids. Nevertheless,
the direct comparison of the Raman maps and the H&E images
allow us to assign this band to nucleic acids and to relate it to
SCC regions with higher concentration of tumor cells. This find-
ing agrees with previous studies reporting higher intensity
Raman bands of nucleic acids in on other solid tumors (e.g.,
skin16 and breast14) compared to normal tissue.
Next, we investigated samples containing lepidic adenocar-
cinoma and adenocarcinoma with necrosis. A total of 18,825
Raman spectra were collected from three adenocarcinoma
tissue samples from three patients. Figure 5 presents two typical
examples.
Sample (a) in Fig. 5 presents a lepidic pattern of cancerous
gland. The area analyzed by Raman spectroscopy was structur-
ally homogenous. The pseudocolor k-means image shows that
Fig. 2 Spectral mapping of lung tissues that generated strong laser-induced fluorescence emission that
fully swamped the Raman bands. Left panels present typical spectra at three selected positions, indi-
cated by a circle, a square, and a triangle, represented in the corresponding H&E images (right panels).
Insets represent the tissue areas analyzed. (a) A sample with adenocarcinoma and (b) nontumorous lung
tissue. Scale bar: 1 mm.
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Fig. 3 Spectral mapping of nontumorous lung tissue [two typical samples included (a) and (b)]. Left pan-
els present spectral maps obtained by k -means clustering from which centroid spectra with the most
intense Raman bands were selected. The spectra in the two middle panels are prior and after prepro-
cessing; the corresponding H&E images are displayed in the right panels (insets represent the tissue
areas analyzed). Scale bar: 1 mm.
Fig. 4 Raman measurement of lung tumor tissues containing SCC. The area highlighted in the
microscopic H&E image (right panels) has its k -means cluster image represented in the left panels.
The average unprocessed Raman spectra alongside the normalized spectra from the mentioned
(1 and 2, respectively) clusters are displayed in the two middle panels. Scale bar indicate 1 mm.
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Fig. 5 Raman measurement of lung adenocarcinoma tissues. The tissue in (a) represents lepidic
pattern adenocarcinoma; (b)–(e) represent various tissue structures of the same tumor tissue pre-
sented in the right panels. The regions consist of: (b) early stage necrosis, (c) late stage necrosis,
(d) viable tumour cells, necrosis and stroma, and (e) stroma with viable tumor cells grouped in gland
shape. For each, the k -means-based image is displayed in the left panel, with corresponding average
Raman spectra plotted. Scale bar: 1 mm.
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two major clusters accounted for 71% of the analyzed area, for
which the centroid spectra contained well-defined Raman
bands. These clusters match the pattern observed in the H&E
image and represent the tumor cells lining the alveolar walls.
Overall, the centroid spectra of tissue (a) shows similar
Raman bands and fluorescence background as observed for
SCC and normal lung tissue. Nevertheless, one main difference
is the 1209 cm−1 band, assigned tentatively to tryptophan and
phenylalanine,32 which is more pronounced compared to SCC.
Also there are differences in the shapes of the bands at 1302 and
1335 cm−1. Finally, the Raman band assigned to tryptophan at
1618 cm−1 is more intense for the adenocarcinoma sample (a)
compared to the SCC samples.
The second tissue presented in Fig. 5 had a highly hetero-
geneous structure and several regions were investigated by
Raman mapping: early stage necrosis [Fig. 5(b)], late stage
necrosis [Fig. 5(c)], a mixed region of viable cells, necrosis and
stroma [Fig. 5(d)], and a region of stroma with viable tumor cells
grouped in a gland shape [Fig. 5(e)]. For the region of early
necrosis [Fig. 5(b)], the centroid spectra for the eight clusters
selected the k-means had overall similar Raman spectral char-
acteristics, confirming the low level of structural heterogeneity.
However, the spectra of this region showed the lowest levels of
laser-induced fluorescence compared to all other samples inves-
tigated. The Raman dataset acquired from the region of late
necrosis was analyzed using 20 clusters. While no significant
differences were observed for the Raman bands, strong fluores-
cence emission (higher than 10,000 counts) dominated 16 cent-
roid spectra, swamping any Raman bands. For the remaining
four clusters, accounting for 87% of the Raman map, the fluo-
rescence varied between 700 and 3500 counts and the Raman
bands were clearly discernible. The spectra from the late
necrosis region presented a band at 1415 cm−1 not assigned
in the literature and not present in the other adenocarcinoma tis-
sue structure. Additionally, we observed differences in the shape
of some Raman bands in the region 1550 to 1700 cm−1; this
region had more intense and marked bands assigned to por-
phyrin and tryptophan at 1518, 1552, and 1612 cm−1.12
For the region containing connective tissue, the k-means
cluster analysis provides good discrimination between the con-
nective tissue and the regions containing larger numbers of via-
ble cells. Similar to the spectra measured for SCC, the spectra of
stroma show a higher fluorescence background, whereas the
Raman bands assigned to nucleic acids have higher intensity
in the regions with larger number of tumor cells.
Overall, we observed spectral differences between the struc-
tures in tissue (b). The bands assigned to protein backbone
stretching νðC─CÞ and collagen identified at 942 cm−1 for non-
malignant and malignant tissues a shifted its maximum at 958
and 956 cm−1 for the late necrosis region and mixed region,
respectively. The 1552 and 1518 cm−1 corresponding to por-
phyrin vibrations had the highest intensity in the regions of most
advanced stage of necrosis, an observation reported in a study
that shows that higher contents of porphyrins were observed in
necrotic regions of tissues.4
Finally, we compared all Raman spectra of nontumorous and
cancerous lung tissue to investigate whether the spectral
differences between normal and cancerous lung tissues are
larger than the inter- and intrapatience variance. Figure 6
presents the average Raman spectra for healthy lung tissue,
adenocarcinoma and SCC after subtraction of the fluorescence
baseline. The largest intensity variations in the Raman spectra
were observed for nontumorous lung tissue. Subtler variations
spread over the entire spectral range were observed for SCC and
adenocarcinoma. Although most of the spectral variance can be
accounted on interpatient variability, variations in fluorescence
background can also lead to spectral distortions after the sub-
traction of the baseline (e.g., 800 to 900 cm−1 region).
The mean spectra of SCC and adenocarcinoma are similar
with slight differences in relative intensity of certain bands, such
as 906 to 996, 1031 to 1110, the 1445 cm−1 assigned to phos-
pholipids and proteins, and peak specific to SCC at 1394 and
1413 cm−1. At the same time, the intensities of bands at 790,
814, and 855 cm−1 are higher for nontumorous tissues com-
pared to tumor tissues, as also reported previously.10,25 A similar
behavior is observed for the nontumorous samples which have
strongest signal for the peaks at 1248, 1269 cm−1 from amide
III, collagen, tryptophan, and phospholipids vibrations and at
1618 cm−1 from tryptophan and porphyrin.
The polynomial curve fitting method used as a baseline sub-
traction to remove the fluorescence background can lead to spec-
tral artefacts in the cases of high level of fluorescence. To
minimize the artefacts, a threshold criterion was implemented
Fig. 6 (a) Mean Raman spectra of normal lung tissue (green), adeno-
carcinoma (dotted blue), and squamous cell carcinoma (orange).
Each spectrum is the average of around 18,000 spectra from 3
patients (normal), 19,000 spectra from 3 patients (adenocarcinoma),
and 16,000 spectra from 5 patients (squamous cell carcinoma). The
regions shaded in light gray highlight the main spectral differences
between the three types. (b) The shaded regions indicate2 standard
deviation from the mean. The spectra are represented on the same
intensity scale and are offset for clarity.
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based on the calculation of the signal-to-noise ratio (SNR) from
the peak at 1450 cm−1. The SNR for a specific Raman band (y) is
defined as SNR ¼ Sσy, where S represent the peak height and σy is
the standard deviation of the peak height. By discarding the low-
est value of SNR (SNR <2), the spectra with small Raman bands
contribution overshadowed in an intense fluorescence back-
ground were removed. We applied this method to the database
and we obtained a reduced spectral dataset including 2497 spectra
from nonmalignant tissue, 2518 spectra from adenocarcinoma,
and 2879 spectra from SCC. This dataset was then further ana-
lyzed by PCA. Figure 7 presents the scores and the loading of the
first two principal components PC-1 and PC-2 which accounted
for 24% and 7% of the variance. The results in Fig. 7 show that
discrimination between healthy tissue, adenocarcinoma, and SCC
can be achieved. The PC-1 versus PC-2 plot in Fig. 7(a) shows
two distinct clouds of data points that separate nontumorous and
tumorous tissues. Figure 7(b) shows that the loadings of the prin-
cipal components responsible for the spectral separation between
the three types of lung tissue contain complex patterns of positive
and negative bands, suggesting that the separation is based on a
complex molecular pattern. The nontumorous tissues are
characterized by positive values of PC-1, including Raman bands
assigned to phenylalanine (1002 and 1605 cm−1), amino acids
(1172, 1210, and 1545 cm−1) and haemoglobin (1620 cm−1).
The groups of data from SCC and adenocarcinoma are located
in the negative part of PC-1 illustrating the contribution from the
peaks from proteins (963 cm−1), phospholipids (1092 cm−1), and
collagen (1488 cm−1) in their spectra.
4 Conclusions
In this study, we analyzed the Raman spectral maps obtained
from fresh normal and malignant lung tissue samples. The
Raman mapping measurements revealed differences in the
molecular composition of normal lung tissue, adenocarcinoma,
and SCC. Molecular heterogeneity of the tissue samples was
well captured by the k-means clustering analysis of the
Raman mapping datasets, as confirmed by the correlation with
the adjacent H&E stained tissue sections. The results indicated
that the fluorescence background varied considerably even in
samples that appear structurally uniform in the H&E images,
both for normal and tumor tissue.
Fig. 7 (a) PCA of the Raman spectra of nonmalignant lung tissue, adenocarcinoma, and squamous cell
carcinoma tissue samples, (b) PC-1 and PC-2 loading, and (c) assignments of the positive (+) and neg-
ative (−) peaks appearing in the loading of PC-1 and PC-2.
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Experimental data showed that there were characteristic
Raman peaks to discriminate between malignant and nonmalig-
nant lung tissues and between adenocarcinoma, and SCC tis-
sues. These results indicate the potential to develop Raman
classifications models for lung tissues based on the Raman spec-
tral differences at the microscopic level, which can be used for
tissue diagnosis or treatment stratification.
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